Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy

被引:16
作者
Blackshear, Joseph L. [1 ]
Kusumoto, Hana [5 ]
Safford, Robert E. [1 ]
Wysokinska, Ewa [6 ]
Thomas, Colleen S. [2 ]
Waldo, Oral A. [7 ]
Stark, Mark E. [3 ]
Shapiro, Brian P. [1 ]
Ung, Steven [1 ]
Moussa, Issam [8 ]
Agnew, Richard C. [4 ]
Landolfo, Kevin [4 ]
Chen, Dong [9 ]
机构
[1] Mayo Clin Florida, Dept Cardiovasc Dis, Jacksonville, FL USA
[2] Mayo Clin Florida, Dept Hlth Sci Res, Jacksonville, FL USA
[3] Mayo Clin Florida, Div Gastroenterol & Hepatol, Jacksonville, FL USA
[4] Mayo Clin Florida, Div Thorac & Cardiovasc Surg, Jacksonville, FL USA
[5] Univ Florida, Gainesville, FL USA
[6] Willmar Canc Ctr, Willmar, MN USA
[7] Mayo Clin Arizona, Cardiovasc Dis Fellowship Program, Scottsdale, AZ USA
[8] First Coast Cardiovasc, Jacksonville, FL USA
[9] Mayo Clin, Div Hematopathol, Rochester, MN USA
关键词
OUTFLOW TRACT OBSTRUCTION; SURGICAL SEPTAL MYECTOMY; NATRIURETIC PEPTIDE; AORTIC-STENOSIS; VARIABILITY; CONTROVERSY; BIOMARKERS; MANAGEMENT; GRADIENT; SURVIVAL;
D O I
10.1016/j.amjcard.2015.11.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Degraded by shear stress, loss of high-molecular-weight multimers of von Willebrand factor (VWF) correlates strongly with pressure gradient in aortic stenosis (AS) and obstructive hypertrophic cardiomyopathy (HC). We assessed VWF tests before and after interventions in HC and contrasted the severity of abnormalities in HC to patients with AS, mitral regurgitation, and left ventricular assist devices. Ninety patients with median (interquartile range) age 66 (53 to 72) years, 51% men, with HC had assessments of 3 VWF parameters and B-type natriuretic peptide before and after 26 discreet medical/pacing interventions, 22 alcohol septal ablations, and 28 ventricular septal myectomies. VWF multimers were abnormal in 87% of patients with obstructive HC versus 48% of patients with latent obstruction (p = 0.0001). VWF measurements correlated with peak instantaneous left ventricular outflow tract gradient, Spearman p 0.51 to 0.61, p <0.0001. For B-type natriuretic peptide, correlation with left ventricular outflow tract gradient was weaker, p = 0.37, p = 0.0005, but stronger with septal thickness or mitral E/e'. In pre-/post-medical treatment of HC, VWF multimers were abnormal in 73%/68% of patients, p = 0.74; pre-/postseptal ablation 74%/26%, p = 0.0035; and pre-/post-septal myectomy 75%/0%, p <0.0001. In obstructive HC, the degree VWF multimer loss was greater than in severe AS or severe mitral regurgitation and overlapped that seen in left ventricular assist devices. In conclusion, VWF activity indexes were predictably abnormal in patients with HC with resting obstruction to a degree where bleeding could be anticipated, accurately reflected gradient changes after intervention, and demonstrated complete normalization after septal myectomy. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 30 条
[1]   Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von Willebrand syndrome [J].
Blackshear, J. L. ;
Stark, M. E. ;
Agnew, R. C. ;
Moussa, I. D. ;
Safford, R. E. ;
Shapiro, B. P. ;
Waldo, O. A. ;
Chen, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (02) :191-196
[2]   Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation [J].
Blackshear, J. L. ;
Wysokinska, E. M. ;
Safford, R. E. ;
Thomas, C. S. ;
Shapiro, B. P. ;
Ung, S. ;
Stark, M. E. ;
Parikh, P. ;
Johns, G. S. ;
Chen, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) :1966-1974
[3]   Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study) [J].
Blackshear, Joseph L. ;
Wysokinska, Ewa M. ;
Safford, Robert E. ;
Thomas, Colleen S. ;
Stark, Mark E. ;
Shapiro, Brian P. ;
Ung, Steven ;
Johns, Gretchen S. ;
Chen, Dong .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (03) :374-381
[4]   Hypertrophic Obstructive Cardiomyopathy, Bleeding History, and Acquired von Willebrand Syndrome: Response to Septal Myectomy [J].
Blackshear, Joseph L. ;
Schaff, Hartzell V. ;
Ommen, Steve R. ;
Chen, Dong ;
Nichols, William L. .
MAYO CLINIC PROCEEDINGS, 2011, 86 (03) :219-224
[5]   Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis [J].
Cambronero, Francisco ;
Marin, Francisco ;
Roldan, Vanessa ;
Hernandez-Romero, Diana ;
Valdes, Mariano ;
Lip, Gregory Y. H. .
EUROPEAN HEART JOURNAL, 2009, 30 (02) :139-151
[6]   Effects of Transcutaneous Aortic Valve Implantation on Aortic Valve Disease-Related Hemostatic Disorders Involving von Willebrand Factor [J].
Caspar, Thibault ;
Jesel, Laurence ;
Desprez, Dominique ;
Grunebaum, Lelia ;
Samet, Hafida ;
Trinh, Annie ;
Petit-Eisenmann, Helene ;
Kindo, Michel ;
Ohlmann, Patrick ;
Morel, Olivier .
CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (06) :738-743
[7]   B-Type Natriuretic Peptide Clinical Activation in Aortic Stenosis [J].
Clavel, Marie-Annick ;
Malouf, Joseph ;
Michelena, Hector I. ;
Suri, Rakesh M. ;
Jaffe, Allan S. ;
Mahoney, Douglas W. ;
Enriquez-Sarano, Maurice .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (19) :2016-2025
[8]   Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy [J].
Fernandes, Fabio ;
Arteaga-Fernandez, Edmundo ;
Antunes, Murillo de Oliveira ;
Buck, Paula ;
Carneiro Marsiglia, Julia Daher ;
Matsumoto, Afonso ;
Nastari, Luciano ;
Krieger, Jose Eduardo ;
Pereira, Alexandre Costa ;
Mady, Charles .
JOURNAL OF CARDIAC FAILURE, 2012, 18 (07) :564-568
[9]   Von Willebrand disease-associated angiodysplasia: a few answers, still many questions [J].
Franchini, Massimo ;
Mannucci, Pier Mannuccio .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (02) :177-182
[10]  
Gersh BJ, 2011, J AM COLL CARDIOL, V58, P2703, DOI 10.1016/j.jacc.2011.10.825